AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Folding rulers in shape of a stock curve

Is your physician well-being strategy working? 9 things to know

| 16 Min Read
Figure sits on a stack of books alongside health data

This doctor shares why physicians can make great entrepreneurs

| 7 Min Read
Military veteran speaking with another individual

Accelerated PTSD care offers faster relief for veterans

| 7 Min Read
David Purow, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about detoxing

| 5 Min Read